INFUSION REACTION

Clinical trials for INFUSION REACTION explained in plain language.

Never miss a new study

Get alerted when new INFUSION REACTION trials appear

Sign up with your email to follow new studies for INFUSION REACTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Completed 1

New plan aims to tame lung cancer treatment side effects

Disease control Not yet recruiting

This study tests a special care plan (CEPM) to help manage side effects like rashes and infusion reactions in people with advanced EGFR-mutated lung cancer taking the drug amivantamab. About 122 Chinese patients will take part. The goal is to see if this plan improves quality of …

Matched conditions: INFUSION REACTION

Phase: PHASE4 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control

Last updated May 14, 2026 12:04 UTC

INFUSION REACTION

Get alerted when new INFUSION REACTION trials appear

New plan aims to tame lung cancer treatment side effects